Eos Advisory
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
TaiSan raises £4.7m in funding led by Eos Advisory and Mercia Ventures for solid-state sodium-ion batteries
TaiSan develops solid-state sodium-ion batteries that are lighter and more compact than existing sodium-ion and lithium-ion alternatives. Its technology is designed for applications such as electric bikes, scooters, vehicles and power tools, offering longer service life and greater safety than conventional flammable liquid electrolytes.
Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
Scarlet Therapeutics develops engineered red blood cells designed to treat metabolic diseases and address shortages in rare blood supplies. Scarlet Therapeutics uses synthetic biology and proprietary cell line technology to create lab-grown red blood cells that can be manufactured at scale for therapeutic and transfusion use.
EnsiliTech raises £4.5m seed round led by Eos Advisory to transform global medicine storage and transport
EnsiliTech develops technology that stabilises vaccines and biologics at high temperatures, removing the need for cold-chain storage and improving global access to medicines.
Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies
Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.
Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems
Concinnity Genetics develops RNA based control systems that allow gene and cell therapies to be adjusted after dosing, improving safety and flexibility in advanced medical treatments.
Naturbeads lands £8m Series A led by EOS to tackle microplastic pollution with sustainable cellulose microspheres
Naturbeads produces biodegradable cellulose microspheres that replace microplastics in everyday products, enabling manufacturers to meet regulatory requirements without compromising performance.
More venture news
- 27 Jul 2026
Nuclear TurbinesNuclear Turbines raises £15m led by IQ Capital to develop compact, low-cost advanced nuclear power systems
EquityEnergy - 21 Jul 2026
HALO X-ray TechnologiesHALO X-ray Technologies lands funding led by Agilent Technologies for X-ray diffraction screening of airport baggage
EquityDeep Tech - 24 Jul 2026
TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
